Table 4. Physicochemical Properties of Synthesized Pyrazoline Analogs (2a–2q).
compound no. | mol. formula | mol. wt (g/mol) | no. HBAa | no. HBDb | mol. Log Pc | mol. Log Sd (mg/L) | mol. PSAe A2 | drug-likeness model score |
---|---|---|---|---|---|---|---|---|
2a | C21H17FN2O | 332.13 | 2 | 1 | 5.79 | 0.65 | 30.47 | 0.19 |
2b | C25H26N2O | 370.20 | 2 | 1 | 7.49 | 0.45 | 30.47 | 0.96 |
2c | C21H17BrN2O | 392.05 | 2 | 1 | 6.56 | 0.42 | 30.47 | 0.01 |
2d | C24H24N2O4 | 404.17 | 5 | 1 | 5.72 | 1.63 | 53.53 | 0.42 |
2e | C22H20N2O2 | 344.15 | 3 | 1 | 5.68 | 1.27 | 38.01 | 0.24 |
2f | C23H23N3O | 357.18 | 2 | 1 | 5.79 | 1.02 | 33.27 | 0.08 |
2g | C23H22N2O3 | 374.16 | 4 | 1 | 5.40 | 2.23 | 45.73 | 0.27 |
2h | C22H18N2O3 | 358.13 | 4 | 2 | 5.53 | 2.13 | 58.88 | 0.41 |
2i | C19H16N2OS | 320.10 | 3 | 1 | 5.25 | 8.50 | 31.49 | –0.36 |
2j | C22H19N3O2 | 357.15 | 3 | 3 | 4.37 | 4.05 | 64.53 | 0.57 |
2k | C25H27N3O | 385.22 | 2 | 1 | 6.53 | 0.51 | 33.20 | 0.23 |
2l | C21H18N2O | 314.14 | 2 | 1 | 5.73 | 0.76 | 30.47 | –0.45 |
2m | C22H17F3N2O | 382.13 | 2 | 1 | 6.55 | 0.46 | 30.47 | –0.69 |
2n | C22H17F3N2O | 382.13 | 2 | 1 | 6.60 | 0.30 | 30.47 | –0.44 |
2o | C22H17F3N2O | 382.13 | 2 | 1 | 6.67 | 0.40 | 30.47 | –0.32 |
2p | C23H22N2O | 342.17 | 2 | 1 | 6.82 | 0.49 | 30.47 | –0.06 |
2q | C22H17N3O | 339.14 | 3 | 1 | 5.33 | 6.10 | 47.52 | –0.29 |
The table above depicts all of Lipinski’s RO5 components, that is, the number of HBAs.
Number of HBDs.
Octanol–water partition coefficient.
Measured solubility.
Total polar surface area.